Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HRS-6208 in Advanced Breast Cancer
NCT07389733Phase 2Recruiting
- Sponsor
- Shandong Suncadia Medicine Co., Ltd.
- Start
- Mar 2026
- Primary completion
- Dec 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HRS-6208 in breast cancer, sponsored by Shandong Suncadia Medicine Co., Ltd.. Started Mar 2026; status: recruiting.
02
Drugs
HRS-6208
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT07389733.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07389733.